Martin Johnson

Martin D. Johnson works for Eli Lilly and Company in Synthetic Molecule Design and Development. He received his PhD in ChE from the University of Michigan in 2000, and his undergraduate in ChE from Virginia Tech. Prior to joining Eli Lilly in 2005, he worked as a process research engineer at Union Carbide and The Dow Chemical Company. His group designed and developed continuous reactors for drug substance manufacturing at Eli Lilly, enabling chemistries that were not amenable to scale up batch. Dr. Johnson was awarded the 2016 ACS Award for Affordable Green Chemistry for work with continuous aerobic oxidations, and the 2016 AIChE Award for Outstanding Contribution to QbD for Drug Substance for implementation of continuous processes. Recently his group has been applying CRE concepts to improve peptide and oligonucleotide syntheses.